Welchol en es it fr

Welchol Brand names, Welchol Analogs

Welchol Brand Names Mixture

  • No information avaliable

Welchol Chemical_Formula

C2H7NS

Welchol RX_link

No information avaliable

Welchol fda sheet

Welchol msds (material safety sheet)

Welchol Synthesis Reference

No information avaliable

Welchol Molecular Weight

77.1497 g/mol

Welchol Melting Point

98 oC

Welchol H2O Solubility

No information avaliable

Welchol State

Solid

Welchol LogP

-0.196

Welchol Dosage Forms

Capsule (50 mg, 150 mg)

Welchol Indication

Given intravenously or orally to treat radiation sickness. The bitartrate has been used for the oral treatment of nephropathic cystinosis.

Welchol Pharmacology

People born without the ability to metabolize the amino acid cystine suffer from cystinosis, a rare inherited disorder characterized by the deposition and accumulation of cystine crystals throughout the body. These crystals cause considerable damage, particularly in the kidney. Kidney failure can occur by the age of 10 in untreated patients. Cysteamine prevents the accumulation of cystine crystals and is prescribed to prevent further kidney damage. Cysteamine helps to convert cystine into less harmful chemical forms that can be removed from cells.

Welchol Absorption

No information avaliable

Welchol side effects and Toxicity

Symptoms of overdose may include convulsions (seizures), increased thirst and unusual tiredness or weakness.

Welchol Patient Information

No information avaliable

Welchol Organisms Affected

Humans and other mammals